NZ332628A - 3-hydroxy-4-hydroxy amino substituted succinyl derivatives of tertiary leucine or phenylalanine which are inhibitors of the production of s-CD23 and the secretion of TNF - Google Patents

3-hydroxy-4-hydroxy amino substituted succinyl derivatives of tertiary leucine or phenylalanine which are inhibitors of the production of s-CD23 and the secretion of TNF

Info

Publication number
NZ332628A
NZ332628A NZ332628A NZ33262897A NZ332628A NZ 332628 A NZ332628 A NZ 332628A NZ 332628 A NZ332628 A NZ 332628A NZ 33262897 A NZ33262897 A NZ 33262897A NZ 332628 A NZ332628 A NZ 332628A
Authority
NZ
New Zealand
Prior art keywords
compound
hydroxy
formula
alkyl
compound according
Prior art date
Application number
NZ332628A
Other languages
English (en)
Inventor
Stuart Bailey
Derek Richard Buckle
Andrew Faller
David Glynn Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NZ332628A publication Critical patent/NZ332628A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ332628A 1996-05-10 1997-05-06 3-hydroxy-4-hydroxy amino substituted succinyl derivatives of tertiary leucine or phenylalanine which are inhibitors of the production of s-CD23 and the secretion of TNF NZ332628A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9609794.4A GB9609794D0 (en) 1996-05-10 1996-05-10 Novel compounds
PCT/EP1997/002433 WO1997043249A1 (en) 1996-05-10 1997-05-06 INHIBITORS OF THE PRODUCTION OF s-CD23 AND THE SECRETION OF TNF

Publications (1)

Publication Number Publication Date
NZ332628A true NZ332628A (en) 2000-06-23

Family

ID=10793494

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ332628A NZ332628A (en) 1996-05-10 1997-05-06 3-hydroxy-4-hydroxy amino substituted succinyl derivatives of tertiary leucine or phenylalanine which are inhibitors of the production of s-CD23 and the secretion of TNF

Country Status (21)

Country Link
US (1) US6235753B1 (ja)
EP (1) EP0918747B1 (ja)
JP (1) JP2000510473A (ja)
KR (1) KR20000010892A (ja)
AR (1) AR007060A1 (ja)
AT (1) ATE246673T1 (ja)
AU (1) AU2897397A (ja)
BR (1) BR9709450A (ja)
CA (1) CA2253590A1 (ja)
CO (1) CO4990945A1 (ja)
CZ (1) CZ363198A3 (ja)
DE (1) DE69723984T2 (ja)
ES (1) ES2205218T3 (ja)
GB (1) GB9609794D0 (ja)
IL (1) IL126860A0 (ja)
NO (1) NO985214L (ja)
NZ (1) NZ332628A (ja)
PL (1) PL329855A1 (ja)
TR (1) TR199802271T2 (ja)
WO (1) WO1997043249A1 (ja)
ZA (1) ZA973964B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020082200A1 (en) * 1994-07-13 2002-06-27 Smithkline Beecham P.1.C. Use of inhibitors of human S-CD23
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
AUPO721997A0 (en) * 1997-06-06 1997-07-03 Queensland Institute Of Medical Research, The Anticancer compounds
EP1030851B1 (en) * 1997-11-12 2005-01-12 Darwin Discovery Limited Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
GB9813451D0 (en) * 1998-06-22 1998-08-19 Smithkline Beecham Plc Novel compounds
GB9922825D0 (en) * 1999-09-25 1999-11-24 Smithkline Beecham Biolog Medical use
US6541661B1 (en) 1999-11-23 2003-04-01 Methylgene, Inc. Inhibitors of histone deacetylase
GB9930754D0 (en) * 1999-12-29 2000-02-16 Smithkline Beecham Plc Novel compounds
US7652036B2 (en) 2003-02-25 2010-01-26 Topotarget Uk Limited Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors
GB0818907D0 (en) * 2008-10-15 2008-11-19 Isis Innovation Histone lysine demethylase inhibitors
SG176010A1 (en) 2009-05-28 2011-12-29 Novartis Ag Substituted aminobutyric derivatives as neprilysin inhibitors
AU2010251967B9 (en) * 2009-05-28 2014-04-03 Novartis Ag Substituted aminopropionic derivatives as neprilysin inhibitors
US8945575B2 (en) 2009-12-01 2015-02-03 Trustees Of Boston University Treatment of IgE-mediated disease
JP6295277B2 (ja) 2013-02-14 2018-03-14 ノバルティス アーゲー Ｎｅｐ（中性エンドペプチダーゼ）阻害剤としての置換ビスフェニルブタン酸ホスホン酸誘導体
CA2900226A1 (en) 2013-02-14 2014-08-21 Novartis Ag Substituted bisphenyl butanoic acid derivatives as nep inhibitors with improved in vivo efficacy
CA2963875A1 (en) * 2014-11-19 2016-05-26 Actelion Pharmaceuticals Ltd Antibacterial benzothiazole derivatives
CN113194954A (zh) 2018-10-04 2021-07-30 国家医疗保健研究所 用于治疗角皮病的egfr抑制剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9215665D0 (en) * 1992-07-23 1992-09-09 British Bio Technology Compounds
ES2144819T3 (es) * 1994-01-20 2000-06-16 British Biotech Pharm L-terc-leucina-2-piridilamida.
GB9414157D0 (en) * 1994-07-13 1994-08-31 Smithkline Beecham Plc Medical use
US5562917A (en) 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
DE19506492C2 (de) 1995-02-24 2003-05-08 Focke & Co Einrichtung zum Speichern von Zigaretten oder dergleichen
US5570079A (en) 1995-04-24 1996-10-29 Dockery; Devan Home security system for detecting an intrusion into a monitored area by an infrared detector

Also Published As

Publication number Publication date
EP0918747A1 (en) 1999-06-02
PL329855A1 (en) 1999-04-12
JP2000510473A (ja) 2000-08-15
NO985214D0 (no) 1998-11-09
CZ363198A3 (cs) 1999-06-16
WO1997043249A1 (en) 1997-11-20
NO985214L (no) 1998-12-01
CO4990945A1 (es) 2000-12-26
BR9709450A (pt) 1999-08-10
US6235753B1 (en) 2001-05-22
TR199802271T2 (xx) 2000-08-21
KR20000010892A (ko) 2000-02-25
AR007060A1 (es) 1999-10-13
AU2897397A (en) 1997-12-05
ES2205218T3 (es) 2004-05-01
ZA973964B (en) 1998-11-09
DE69723984D1 (de) 2003-09-11
IL126860A0 (en) 1999-09-22
CA2253590A1 (en) 1997-11-20
DE69723984T2 (de) 2004-06-09
GB9609794D0 (en) 1996-07-17
EP0918747B1 (en) 2003-08-06
ATE246673T1 (de) 2003-08-15

Similar Documents

Publication Publication Date Title
NZ332628A (en) 3-hydroxy-4-hydroxy amino substituted succinyl derivatives of tertiary leucine or phenylalanine which are inhibitors of the production of s-CD23 and the secretion of TNF
US20030195191A1 (en) N-sulfonyl hydroxamic acid derivatives as inhibitors of cd23
AU725056B2 (en) Hydroxamic acid based collagenase inhibitors
US6458779B1 (en) Hydroxamic acid derivatives as inhibitors of the production of human CD23 and of the TNF release
US20040077727A1 (en) Hydroxamic acid derivative as inhibitor of the formation of soluble human CD23
EP0901464A1 (en) Hydroxamic acid based inhibitors of the formation of cd23 and tnf
US20030199571A1 (en) (Hetero) Bicyclymethanesulfonylamino-substituted hydroxamic acid derivatives
EP1599444A1 (en) Sulphonyl hydroxamic acid derivatives as inhibitors of s-cd23
US20040209822A1 (en) Novel compounds
EP1448529B1 (en) Sulfone derivatives suitable for the treatment of autoimmune diseases and allergies
WO2001044221A1 (en) Hydroxamic acid derivatives as inhibitors of human cd23 and of the tnf release